Skip to content

Red blood cell transfusion, lowest haemoglobin level, and their association with mortality and length of hospital stay in surgical patients.

Associations of red blood cell transfusion and nadir haemoglobin with mortality and length of stay in surgical patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12617001645347
Acronym
None
Enrollment
60955
Registered
2017-12-19
Start date
2018-02-12
Completion date
2018-02-12
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Anaemia, a global public health problem, is common in developing and developed countries, particularly among hospitalized patients. The World Health Organization defines anaemia as a haemoglobin concentration below 130 grams per litre in males and 120 grams in litre in females. A recent systematic review and meta-analysis on preoperative anaemia and outcomes after cardiac and non-cardiac surgery reported 39% of patients were admitted anaemic. These anaemic patients had three-fold higher odds of mortality, four-fold higher odds of acute kidney injury and twice the odds of infection. Not surprisingly, anaemia was also associated with increased transfusion, with anaemic patients five-times more likely to receive a red blood cell transfusion. As these results indicate, red blood cell transfusions are often administered to correct low haemoglobin levels. However, correcting anaemia with transfusion is problematic as red blood cell transfusion has a dose-dependent association with increased mortality, morbidity, hospital and ICU length of stay, readmissions, and cost. Large risk-adjusted observational studies demonstrate that even transfusing a single unit of red blood cells is associated with increased adverse outcomes in surgical patients, thus recommending caution before transfusing. In an attempt to find the “optimal” transfusion threshold, many randomized controlled trials have investigated the difference between using restrictive pre-transfusion haemoglobin thresholds compared with liberal thresholds. A restrictive strategy refers to a policy of administering red blood cell transfusions at comparatively lower pre-defined haemoglobin levels, with the goal of minimizing the use of blood. Though not always the case, restrictive transfusion thresholds are often defined as haemoglobin levels between 70 grams per litre and 80 grams per litre and liberal transfusion thresholds are commonly defined as haemoglobin levels between 90 grams per litre and 100 grams per litre. A recent systematic review and meta-analysis published in the Cochrane Library concluded there is no difference in morbidity or mortality between restrictive and liberal transfusion strategies. However, these trials are often confounded by transfusions administered pre-randomization, a lack of comparable transfusion dosing regimens between studies, and at times small differences in actual mean pre-transfusion haemoglobin levels between control and intervention arms. In addition, these randomized controlled trials do not address transfusion efficacy and still leave many important questions unanswered. For example, whether haemoglobin thresholds lower than 70 grams per litre are just as effective as haemoglobin levels higher than 70 grams per litre. Some have suggested lower haemoglobin thresholds may be just as effective. The aim of this study is to determine what effect red blood cell transfusion has on mortality and length of stay at various levels of nadir haemoglobin.

Interventions

1) Presence of a red blood cell transfusion. This will be measured at any time during the patient’s hospital admission. 2) Level of nadir haemoglobin (in grams per litre). This will be the pre-transfusion haemoglobin or nadir haemoglobin in those not transfused.

Sponsors

Royal Perth Hospital
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adults admitted as elective or emergency cases for orthopaedic surgery, gastrointestinal surgery, vascular surgery, urology, cardiothoracic surgery, or neurosurgery to three public hospitals in Western Australia between July 2008 and June 2017.

Exclusion criteria

Any patients transfused fresh frozen plasma, platelets, and cryoprecipitate will be excluded from the study. Also excluded are patients receiving a massive transfusion, patients transfused any blood products 90 days prior to admission, patients with a length of stay of less than 2 days (same day and overnight admissions), patients under the age of 18 years at admission, and patients with no haemoglobin results.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026